Clinical equipoise: Protons and the child with craniopharyngioma

Ruth Conroy, Lavier Gomes, Catherine Owen, Jeffrey Buchsbaum, Verity Ahern

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction Childhood craniopharyngioma is a complex condition to manage. Survival figures are high but the potential for long-term morbidity is great. There is much debate regarding the best management for these tumours with increasing interest in the use of proton beam therapy. We have therefore reviewed our radiotherapy (RT) practice at Westmead Hospital and the literature regarding the use of protons for these children. Methods Three children have received fractionated stereotactic RT for craniopharyngioma at Westmead Hospital since 2007. Each RT plan was reviewed and additional organs at risk were contoured to enable comparison with published proton data. Results Planning target volume coverage was similar with all modalities: with the conformity index ranging from 0.70 to 0.78 in our patients compared with 0.50-0.84 in the published data. RT dose to temporal lobes, hippocampi and whole brain was also similar with protons and photons. Proton beam therapy may give lower dose to the Circle of Willis than stereotactic RT. Conclusion Currently there is no clear evidence that proton beam therapy will improve survival or reduce morbidity for children with craniopharyngioma. However, proton therapy has the potential to reduce RT dose to the Circle of Willis, which may reduce the risk of future cerebrovascular complications. We propose that more resources should be allocated to ensuring these patients are managed by experienced multidisciplinary teams through the continuum from diagnosis to long-term follow-up.

Original languageEnglish
Pages (from-to)379-385
Number of pages7
JournalJournal of Medical Imaging and Radiation Oncology
Volume59
Issue number3
DOIs
StatePublished - Jun 1 2015

Fingerprint

Craniopharyngioma
Proton Therapy
Protons
Radiotherapy
Circle of Willis
Organs at Risk
Morbidity
Survival
Temporal Lobe
Photons
boldenone undecylenate
Hippocampus
Brain
Neoplasms

Keywords

  • children
  • craniopharyngioma
  • protons
  • sequelae
  • stereotactic radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Clinical equipoise : Protons and the child with craniopharyngioma. / Conroy, Ruth; Gomes, Lavier; Owen, Catherine; Buchsbaum, Jeffrey; Ahern, Verity.

In: Journal of Medical Imaging and Radiation Oncology, Vol. 59, No. 3, 01.06.2015, p. 379-385.

Research output: Contribution to journalArticle

Conroy, Ruth ; Gomes, Lavier ; Owen, Catherine ; Buchsbaum, Jeffrey ; Ahern, Verity. / Clinical equipoise : Protons and the child with craniopharyngioma. In: Journal of Medical Imaging and Radiation Oncology. 2015 ; Vol. 59, No. 3. pp. 379-385.
@article{cacb07cc8d4b4429b1a507843c4077f8,
title = "Clinical equipoise: Protons and the child with craniopharyngioma",
abstract = "Introduction Childhood craniopharyngioma is a complex condition to manage. Survival figures are high but the potential for long-term morbidity is great. There is much debate regarding the best management for these tumours with increasing interest in the use of proton beam therapy. We have therefore reviewed our radiotherapy (RT) practice at Westmead Hospital and the literature regarding the use of protons for these children. Methods Three children have received fractionated stereotactic RT for craniopharyngioma at Westmead Hospital since 2007. Each RT plan was reviewed and additional organs at risk were contoured to enable comparison with published proton data. Results Planning target volume coverage was similar with all modalities: with the conformity index ranging from 0.70 to 0.78 in our patients compared with 0.50-0.84 in the published data. RT dose to temporal lobes, hippocampi and whole brain was also similar with protons and photons. Proton beam therapy may give lower dose to the Circle of Willis than stereotactic RT. Conclusion Currently there is no clear evidence that proton beam therapy will improve survival or reduce morbidity for children with craniopharyngioma. However, proton therapy has the potential to reduce RT dose to the Circle of Willis, which may reduce the risk of future cerebrovascular complications. We propose that more resources should be allocated to ensuring these patients are managed by experienced multidisciplinary teams through the continuum from diagnosis to long-term follow-up.",
keywords = "children, craniopharyngioma, protons, sequelae, stereotactic radiotherapy",
author = "Ruth Conroy and Lavier Gomes and Catherine Owen and Jeffrey Buchsbaum and Verity Ahern",
year = "2015",
month = "6",
day = "1",
doi = "10.1111/1754-9485.12264",
language = "English",
volume = "59",
pages = "379--385",
journal = "Journal of Medical Imaging and Radiation Oncology",
issn = "1754-9477",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Clinical equipoise

T2 - Protons and the child with craniopharyngioma

AU - Conroy, Ruth

AU - Gomes, Lavier

AU - Owen, Catherine

AU - Buchsbaum, Jeffrey

AU - Ahern, Verity

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Introduction Childhood craniopharyngioma is a complex condition to manage. Survival figures are high but the potential for long-term morbidity is great. There is much debate regarding the best management for these tumours with increasing interest in the use of proton beam therapy. We have therefore reviewed our radiotherapy (RT) practice at Westmead Hospital and the literature regarding the use of protons for these children. Methods Three children have received fractionated stereotactic RT for craniopharyngioma at Westmead Hospital since 2007. Each RT plan was reviewed and additional organs at risk were contoured to enable comparison with published proton data. Results Planning target volume coverage was similar with all modalities: with the conformity index ranging from 0.70 to 0.78 in our patients compared with 0.50-0.84 in the published data. RT dose to temporal lobes, hippocampi and whole brain was also similar with protons and photons. Proton beam therapy may give lower dose to the Circle of Willis than stereotactic RT. Conclusion Currently there is no clear evidence that proton beam therapy will improve survival or reduce morbidity for children with craniopharyngioma. However, proton therapy has the potential to reduce RT dose to the Circle of Willis, which may reduce the risk of future cerebrovascular complications. We propose that more resources should be allocated to ensuring these patients are managed by experienced multidisciplinary teams through the continuum from diagnosis to long-term follow-up.

AB - Introduction Childhood craniopharyngioma is a complex condition to manage. Survival figures are high but the potential for long-term morbidity is great. There is much debate regarding the best management for these tumours with increasing interest in the use of proton beam therapy. We have therefore reviewed our radiotherapy (RT) practice at Westmead Hospital and the literature regarding the use of protons for these children. Methods Three children have received fractionated stereotactic RT for craniopharyngioma at Westmead Hospital since 2007. Each RT plan was reviewed and additional organs at risk were contoured to enable comparison with published proton data. Results Planning target volume coverage was similar with all modalities: with the conformity index ranging from 0.70 to 0.78 in our patients compared with 0.50-0.84 in the published data. RT dose to temporal lobes, hippocampi and whole brain was also similar with protons and photons. Proton beam therapy may give lower dose to the Circle of Willis than stereotactic RT. Conclusion Currently there is no clear evidence that proton beam therapy will improve survival or reduce morbidity for children with craniopharyngioma. However, proton therapy has the potential to reduce RT dose to the Circle of Willis, which may reduce the risk of future cerebrovascular complications. We propose that more resources should be allocated to ensuring these patients are managed by experienced multidisciplinary teams through the continuum from diagnosis to long-term follow-up.

KW - children

KW - craniopharyngioma

KW - protons

KW - sequelae

KW - stereotactic radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=84930485484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930485484&partnerID=8YFLogxK

U2 - 10.1111/1754-9485.12264

DO - 10.1111/1754-9485.12264

M3 - Article

AN - SCOPUS:84930485484

VL - 59

SP - 379

EP - 385

JO - Journal of Medical Imaging and Radiation Oncology

JF - Journal of Medical Imaging and Radiation Oncology

SN - 1754-9477

IS - 3

ER -